Hemoglobin A1c Biomarker

Overview

Hemoglobin A1c (HbA1c) measures the percentage of hemoglobin in red blood cells that has glucose attached to it, reflecting average blood sugar levels over the past 2–3 months. Because red blood cells live about 3 months, HbA1c gives a longer‑term view of blood sugar control rather than a single “snapshot” like a standard blood glucose test. Higher levels usually indicate higher average blood sugar, which can signal prediabetes or diabetes and increased risk for complications such as eye, kidney, or nerve problems; lower levels within the target range suggest better‑controlled blood sugar. Clinically, it is widely used to help diagnose diabetes, monitor how well treatment is working, and guide changes in medicines, diet, or lifestyle in people with diabetes.

Clinical Use Cases

Screening for and diagnosing type 2 diabetes and prediabetes.
Monitoring long‑term blood sugar control in people with type 1 or type 2 diabetes.
Guiding treatment decisions such as adjusting oral diabetes medications, insulin, or lifestyle plans.
Assessing risk for diabetes‑related complications such as eye, kidney, and nerve disease.
Evaluating the effectiveness of population‑level diabetes‑care programs and quality‑of‑care metrics.

Specimen Types

Whole blood collected in an EDTA (lavender top) tube.

Measurement Methods

High‑performance liquid chromatography (HPLC), often using ion‑exchange columns, as a core laboratory method.
Immunoassay‑based methods that detect glycated hemoglobin using antibodies.
Enzymatic methods that measure glycated hemoglobin via specific enzyme reactions.

Test Preparation and Influencing Factors

Fasting is not required; HbA1c can be measured at any time of day, regardless of meals.
Conditions that shorten or lengthen red‑cell lifespan (e.g., recent heavy blood loss, blood transfusion, hemolytic anemia, aplastic anemia) can falsely lower or raise HbA1c.
Certain hemoglobin variants (e.g., sickle cell trait or disease) may interfere with some HbA1c assays and require special testing or alternative methods.
Iron‑deficiency anemia and some chronic kidney or liver diseases may modestly affect HbA1c values.
Smoking has been associated with slightly higher HbA1c at a given blood glucose level.
Extreme changes in blood sugar over the previous 4–6 weeks may be “weighted” more heavily in the result because red blood cells are younger.